Advocacy Wealth Management Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AWA
Advocacy Wealth Management Services's PFE Position: Q4 2022 in Review
Advocacy Wealth Management Services sold out of Pfizer (PFE) in Q4 2022, closing a stake of 39 shares — an estimated $2K sold.
Advocacy Wealth Management Services first reported a position in PFE in Q2 2013 and held it in 24 quarters. The position peaked at $133K in Q4 2015. 3,265 funds tracked by Wall St. Rank hold PFE as of Q4 2022.
- Advocacy Wealth Management Services reported no remaining Pfizer position as of Q4 2022 after selling out during the quarter.
- Advocacy Wealth Management Services sold 39 Pfizer shares in Q4 2022, an estimated $2K.
- Advocacy Wealth Management Services first reported a position in Pfizer in Q2 2013 and held it in 24 quarters.
- Advocacy Wealth Management Services's Pfizer position peaked at $133K in Q4 2015.
- 3,265 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.
Based on Advocacy Wealth Management Services's 13F filing for Q4 2022, filed 27 Jan 2023.